Chronic obstructive pulmonary disease (COPD) is a widespread disease. In Austria alone, there are between 500,000 and 600,000 sufferers; around ninety per cent of cases are the result of smoking. Now, under the leadership ...
Apr 5, 2012
0
0
The third most deadly disease in the U.S., chronic obstructive pulmonary disease (COPD), appears to be partly driven by the action of immune cells circulating in the blood entering into the tissues of the lungs. UC Davis ...
Mar 21, 2012
0
0
A new study published in the journal Respirology reveals that children who are exposed to passive smoke have almost double the risk of developing chronic obstructive pulmonary disease (COPD) in adulthood compared with non-exposed ...
Mar 15, 2012
0
0
A large population-based study has found that lung function and obstructive airway diseases are strongly and independently associated with increased risk of heart failure. Importantly, say the investigators, this association ...
Feb 25, 2012
0
0
A lung transplant is the only treatment option for patients faced with imminent pulmonary failure. But suitable donor organs are highly susceptible to damage in transit. A team of researchers based at LMU's Walther Straub ...
Feb 1, 2012
0
0
Among men who were current or former heavy smokers, undergoing lung cancer screening with computed tomography (CT) scanning identified a substantial proportion who had chronic obstructive pulmonary disease (COPD), suggesting ...
Oct 25, 2011
0
0
Treatment with the calcium-sensitizing drug levosimendan may be effective in improving muscle function in patients with respiratory muscle weakness, which often accompanies chronic diseases such as chronic obstructive pulmonary ...
Sep 23, 2011
0
0
UCLA researchers have found that the hormone estrogen may help reverse advanced pulmonary hypertension, a rare and serious condition that affects 2 to 3 million individuals in the U.S., mostly women, and can lead to heart ...
Sep 15, 2011
0
0
Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to research from Johns Hopkins University.
Jul 15, 2011
0
0
The CAPACITY study, published Online First and in an upcoming Lancet, shows that pirfenidone reduces the rate of decline of lung function in patients with idiopathic pulmonary fibrosis—a condition of unknown cause affecting ...
May 13, 2011
0
0
